<DOC>
	<DOCNO>NCT00479882</DOCNO>
	<brief_summary>This 20-week clinical trial participant primary hypercholesterolemia mixed dyslipidemia demonstrate effect MK-0524B compare MK-0524A + Simvastatin lipid value .</brief_summary>
	<brief_title>MK-0524B Lipid Study ( MK-0524B-063 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>primary hypercholesterolemia mix dyslipidemia base medical history ( previous diagnosis ) , historic lipid value , otherwise determine optional lipid measurement screen visit meet one follow triglyceride ( TG ) criterion : 1. niacin , statin , fibrate TG &lt; 500 mg/dL within 6 month washout 2. lipid alter therapy lipid alter therapy niacin , statin , fibrate TG &lt; 600 mg/dL within 6 month screen high risk ( coronary heart disease [ CHD ] CHD risk equivalent ) AND statin pregnant breastfeeding , expect conceive study include 14day post study followup Type 1 Type 2 diabetes mellitus statin therapy , poorly control , newly diagnose ( within 3 month Visit 1 ) , recently experience repeat hypoglycemia unstable glycemic control take new recently adjust antidiabetic medication ( exception +/ 10 unit insulin ) within 3 month Visit 1 follow condition : chronic heart failure , uncontrolled/unstable cardiac arrhythmia , unstable hypertension , active chronic hepatobiliary disorder hepatic disease , human immunodeficiency virus ( HIV ) positive , gout ( within 1 year )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>